Investing Profile

Paul Klingenstein

‌

Your Intro Paths to Paul Klingenstein

‌

Find Paul Klingenstein on

Current Investing Position

Aberdare Ventures Managing Partner

Investment Range

$500K - $15.0M

Sweet Spot

$8.0M

Investments On Record

Paul Klingenstein is on these Sector & Stage Rankings

Paul Klingenstein's Investments On Record (6)

Company	StageDateRound Size	Total Raised
MC10	Series UnknownAug 2018$10M Series CDec 2012$10M Series UnknownJan 2012$2M	$60M
Co-investors: Carmichael Roberts (Breakthrough Energy Ventures), Marc Singer (Osage University Partners), Mark Goodman (MassMutual Ventures), Jiong Ma (Braemar Energy Ventures)
Aviir	Series BJun 2013$10M Series BFeb 2013$10M Series UnknownDec 2011$10M Series UnknownJun 2011$3M Series UnknownJan 2010$4M Series UnknownOct 2009$1M Series UnknownDec 2008$8M Series UnknownMar 2008$2M Series BSep 2007$11M	$59M
Co-investors: David Rubin (Merck Global Health Innovation Fund)
Nevro	Series BJul 2011$58M Series ASep 2008$22M SeedDec 2006$6M	$130M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Asish Xavier (Johnson & Johnson Innovation)
Posit Science	Series UnknownMar 2011$3M Series UnknownApr 2009$6M Series BDec 2006$15M	$24M
Conatus Pharmaceuticals	Series BFeb 2011$20M Series AMay 2007$22M	$50M
Co-investors: Jim Scopa (MPM Capital), Shahzad Malik (Advent Life Sciences)
Anacor Pharmaceutical	Series EJan 2009$50M Series CMay 2005$25M Series UnknownNov 2002$4M Series AJul 2002$3M	$87M
Co-investors: Ling Wong (Highbury Group), Anders Hove (Acorn Bioventures)